# Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM

> **NCT03500874** · PHASE3 · TERMINATED · sponsor: **Sun Yat-sen University** · enrollment: 92 (actual)

## Conditions studied

- Colorectal Cancer
- Liver Metastases
- HAI

## Interventions

- **DRUG:** FUDR
- **DRUG:** Oxaliplatin
- **DRUG:** Leucovorin
- **DRUG:** 5FU
- **DRUG:** Irinotecan

## Key facts

- **NCT ID:** NCT03500874
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-05-28
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-08-31
- **Target enrollment:** 92 (ACTUAL)
- **Why stopped:** The study was terminated prematurely due to FUDR production halt in China
- **Last updated:** 2024-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03500874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03500874, "Adjuvant Systemic Chemotherapy With or Without HAI-FUDR in Patients With Resected CRLM". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03500874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*